0.6110USD-6.00%Mkt Cap: 149.60M USDP/E: 3.88Last update: 2026-06-01
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap149.60M USD
Enterprise Value107.25M USD
Revenue (TTM)255.61M USD
Gross Profit55.36M USD
Net Income (TTM)16.33M USD
Revenue/Share1.095 USD
Last Price0.6110 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees65
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)3.88
P/E (Forward)-0.99
PEG—
EV/EBITDA2.35
EV/Revenue0.42
P/S0.62
P/B1.81
EPS (TTM)0.16
EPS (Forward)-0.67
52W Range
0.260061% of range0.8400
52W High0.8400 USD
52W Low0.2600 USD
Profitability
Gross Margin21.66%
Oper. Margin13.19%
EBITDA Margin17.85%
Profit Margin6.88%
ROE18.60%
ROA8.77%
Growth
Revenue Growth87.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF7.71M USD
CapEx (TTM)145.00K USD
FCF Margin-12.80%
FCF Yield-21.87%
Net Debt-48.82M USD
Net Debt/EBITDA-1.07
Balance Sheet
Debt/Equity0.10
Current Ratio1.71
Quick Ratio1.54
Book Value/Sh0.3650 USD
Cash/Share0.2520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 9, 2012
Pay DateFeb 14, 2018
Splits
Last Split1:11
Split DateFeb 14, 2018
Analyst Consensus
Rating—
Target (Mean)3.000 USD
Target Range2.000 USD – 4.000 USD
# Analysts2
Ownership
Shares Out.241.29M
Float238.45M
Insiders1.33%
Institutions0.05%
Short Interest
Short Ratio2.6d
Short % Float9.40%
Short % Out.9.28%
Shares Short21.17M
Short (prev mo.)14.35M
Technical
SMA 500.6858 (-10.9%)
SMA 2000.5164 (+18.3%)
Beta1.18
S&P 52W Chg27.70%
Avg Vol (30d)419.32K
Avg Vol (10d)445.09K
Technical Indicators
RSI (14)45.6
MACD-0.0188
MACD Signal-0.0151
MACD Hist.-0.0037
BB Upper0.7950 USD
BB Middle0.6856 USD
BB Lower0.5763 USD
BB Width31.89%
ATR (14)0.0612 USD
Vol Ratio (20d)0.12x